Trial Profile
Characterisation of Gastric Residence of a Furosemide-containing New Gastric Retention System by Means of MMM Measurement and Determination of Pharmacokinetics, Pharmacodynamics and Safety
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Furosemide (Primary)
- Indications Oedema
- Focus Pharmacokinetics
- Sponsors Lohmann Therapie-Systeme
- 27 May 2015 New trial record